These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons. Yadav K; Sharma M; Ferdinand KC Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):853-62. PubMed ID: 27352986 [TBL] [Abstract][Full Text] [Related]
52. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL. Shah PK Curr Opin Cardiol; 2010 Nov; 25(6):603-8. PubMed ID: 20827180 [TBL] [Abstract][Full Text] [Related]
53. Antilipidemic Drug Therapy Today and in the Future. Kramer W Handb Exp Pharmacol; 2016; 233():373-435. PubMed ID: 26330256 [TBL] [Abstract][Full Text] [Related]
54. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Sahebkar A; Watts GF Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550 [TBL] [Abstract][Full Text] [Related]
55. Management of hypercholesterolaemia in postmenopausal women. Davidson MH; Maki KC; Karp SK; Ingram KA Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776 [TBL] [Abstract][Full Text] [Related]
56. HDL-Targeting Therapeutics: Past, Present and Future. Zakiev E; Feng M; Sukhorukov V; Kontush A Curr Pharm Des; 2017; 23(8):1207-1215. PubMed ID: 27799042 [TBL] [Abstract][Full Text] [Related]
58. Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting. Zheng-Lin B; Ortiz A Drugs; 2018 Feb; 78(2):215-229. PubMed ID: 29299849 [TBL] [Abstract][Full Text] [Related]
59. Choosing the right lipid-regulating agent. A guide to selection. Farmer JA; Gotto AM Drugs; 1996 Nov; 52(5):649-61. PubMed ID: 9118815 [TBL] [Abstract][Full Text] [Related]
60. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism. Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]